MRI-Targeted biopsies outperform standard method in prostate cancer detection
NCT ID NCT02485379
First seen Dec 26, 2025 · Last updated May 22, 2026 · Updated 22 times
Summary
This study tested whether using MRI to guide prostate biopsies finds more aggressive cancers than the usual method of taking random samples. 275 men with suspected prostate cancer each received both standard and MRI-targeted biopsies. The goal was to see if the MRI approach detects more high-grade (Gleason 7 or higher) cancers, potentially reducing missed diagnoses and unnecessary treatments.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
CHU Nancy Brabois
Vandœuvre-lès-Nancy, 54511, France
-
CHU de Saint-Etienne
Saint-Etienne, 42055, France
-
CLIMAL (Centre Libéral Imagerie Médicale Agglomération Lille)
Lille, 59700, France
-
Centre Hospitalier Lyon Sud
Pierre-Bénite, 69495, France
-
Centre Hospitalier St Joseph St Luc
Lyon, 69365, France
-
Clinique Jules Verne
Nantes, 44300, France
-
Clinique Urologique Nantes Atlantis
Saint-Herblain, 44815, France
-
Groupe Hospitalier Pellegrin - CHU de Bordeaux
Bordeaux, 33076, France
-
Hopital Pitie Salpetriere
Paris, 75013, France
-
Hôpital Cochin
Paris, 75014, France
-
Hôpital Edouard Herriot
Lyon, 69437, France
-
Hôpital Européen Georges Pompidou
Paris, 75015, France
-
Hôpital Huriez - CHU de Lille
Lille, 59037, France
-
Hôpital Michallon - CHU de Grenoble
Grenoble, 38043, France
-
Hôpital Necker
Paris, 75015, France
-
Hôpital Privé La Louvière
Lille, 59042, France
-
IRMAS
Saint-Priest-en-Jarez, 42270, France
-
Institut Paoli Calmettes
Marseille, 13273, France
-
Institut Universitaire du Cancer de Toulouse (IUCT) Oncopole - CHU de Toulouse
Toulouse, 31059, France
-
Nouvel Hopital Civil - CHU de Strasbourg
Strasbourg, 67091, France
Conditions
Explore the condition pages connected to this study.